Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Pei Hong Wu"'
Autor:
Tian-Qi Zhang, Zhi-Jun Geng, Meng-Xuan Zuo, Ji-Bin Li, Jin-Hua Huang, Zi-Lin Huang, Pei-Hong Wu, Yang-Kui Gu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-7 (2023)
Abstract Hepatic arterial infusion chemotherapy (HAIC) using a combination of oxaliplatin, fluorouracil, and leucovorin (FOLFOX) has shown promise for hepatocellular carcinoma (HCC) patients classified under Barcelona Clinic Liver Cancer (BCLC) stage
Externí odkaz:
https://doaj.org/article/b8acba41e559430f803d5642c0d9caa6
Autor:
Fang Zheng, Yi-Ji Liao, Mu-Yan Cai, Tian-Hao Liu, Shu-Peng Chen, Pei-Hong Wu, Long Wu, Xiu-Wu Bian, Xin-Yuan Guan, Yi-Xin Zeng, Yun-Fei Yuan, Hsiang-Fu Kung, Dan Xie
Publikováno v:
PLoS Genetics, Vol 17, Iss 12 (2021)
Externí odkaz:
https://doaj.org/article/4530e55a51f144a0b8f0bb26e092e821
Autor:
Wang Li, Lu-Jun Shen, Tao Chen, Xu-Qi Sun, Ying Zhang, Ming Wu, Wan-Hong Shu, Chen Chen, Chang-Chuan Pan, Yun-Fei Xia, Pei-Hong Wu
Publikováno v:
Chinese Journal of Cancer, Vol 35, Iss 1, Pp 1-9 (2016)
Abstract Background Although the prognostic impact of body mass index (BMI) in patients with non-metastatic nasopharyngeal carcinoma (NPC) had been extensively studied, its effect among metastatic NPC patients remains unknown. The purpose of this stu
Externí odkaz:
https://doaj.org/article/135fb894e12a4ac991d01557397e1c0d
Publikováno v:
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
Health care costs can present a significant strain on patients with head and neck cancer. It remains unclear how much prices may vary among hospitals providing care and what factors lead to differences in prices of surgical procedures. A cross-sectio
Autor:
Ming Wu, Rong De Xu, Qing Gou, Xiao Ming Chen, Shan Shan Lian, Zhi Qiang Mo, Zhi Mei Huang, Pei Hong Wu, Feng Shi, Hui Lan Li
Publikováno v:
Radiology. 293:707-715
Background Transarterial chemoembolization (TACE) is an effective downstaging procedure for hepatocellular carcinoma (HCC). However, knowledge of the effectiveness of radiofrequency ablation (RFA) after downstaging of HCC is currently lacking. Purpos
Autor:
Fang Zheng, Yi-Ji Liao, Mu-Yan Cai, Tian-Hao Liu, Shu-Peng Chen, Pei-Hong Wu, Long Wu, Xiu-Wu Bian, Xin-Yuan Guan, Yi-Xin Zeng, Yun-Fei Yuan, Hsiang-Fu Kung, Dan Xie
Publikováno v:
PLoS Genetics, Vol 11, Iss 2, p e1004873 (2015)
Targeted therapy based on adjustment of microRNA (miRNA)s activity takes great promise due to the ability of these small RNAs to modulate cellular behavior. However, the efficacy of miR-101 replacement therapy to hepatocellular carcinoma (HCC) remain
Externí odkaz:
https://doaj.org/article/7961fb4071e841e98ef6a5465374bac3
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0119593 (2015)
The impact of standard chemo-radiotherapy (CRT) as preferred therapy for elderly patients (age≥60 years) with nasopharyngeal carcinoma (NPC) remains unclear. Therefore, a strict matched cohort study was conducted to compare the survival and treatme
Externí odkaz:
https://doaj.org/article/6852a60677734d26a24ec81e06556566
Autor:
Xiao-Fei Lv, Kai Liu, Ying-Wei Qiu, Pei-Qiang Cai, Jing Li, Gui-Hua Jiang, Yan-Jia Deng, Xue-Lin Zhang, Pei-Hong Wu, Chuan-Miao Xie, Ge Wen
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0119339 (2015)
Increasing evidence suggests that cirrhosis may affect the connectivity among different brain regions in patients before overt hepatic encephalopathy (OHE) occurs. However, there has been no study investigating the structural reorganization of these
Externí odkaz:
https://doaj.org/article/4438298ac2ec40838412eaff102bc033
Publikováno v:
World Journal of Gastrointestinal Oncology
BACKGROUND Hepatitis B virus, together with hepatitis C virus, has been recognized as the leading causes of hepatocellular carcinoma (HCC). Long non-coding RNAs (lncRNAs) have been suggested in increasing studies to be the potential prognostic factor
Publikováno v:
Disease Markers, Vol 2019 (2019)
Disease Markers
Disease Markers
Transcription factor activating enhancer binding protein 4 (TFAP4) is established as a regulator of human cancer genesis and progression. Overexpression of TFAP4 indicates poor prognosis in various malignancies. The current study was performed to qua